Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
Medtronic (NYSE: MDT) has scheduled the release of its fourth quarter and full fiscal year 2025 financial results for Wednesday, May 21, 2025. The company will issue a news release at 5:45 a.m. CDT, followed by a video webcast at 7:00 a.m. CDT to discuss the results. The fiscal year 2025 ended on April 25, 2025.
The healthcare technology leader has also announced its earnings release schedule for fiscal year 2026, with quarterly results planned for August 19, 2025, November 18, 2025, February 17, 2026, and May 20, 2026. Medtronic, headquartered in Galway, Ireland, employs over 95,000 people across 150+ countries, developing technologies that treat 70 health conditions including cardiac devices, surgical robotics, and insulin pumps.
Medtronic (NYSE: MDT) ha programmato la pubblicazione dei risultati finanziari del quarto trimestre e dell'intero anno fiscale 2025 per mercoledì 21 maggio 2025. L'azienda rilascerà un comunicato stampa alle 5:45 CDT, seguito da una video trasmissione alle 7:00 CDT per discutere i risultati. L'anno fiscale 2025 si è concluso il 25 aprile 2025.
Il leader nella tecnologia sanitaria ha inoltre annunciato il calendario delle comunicazioni degli utili per l'anno fiscale 2026, con risultati trimestrali previsti per il 19 agosto 2025, 18 novembre 2025, 17 febbraio 2026 e 20 maggio 2026. Medtronic, con sede a Galway, Irlanda, impiega oltre 95.000 persone in più di 150 paesi, sviluppando tecnologie che trattano 70 condizioni di salute, tra cui dispositivi cardiaci, robotica chirurgica e pompe per insulina.
Medtronic (NYSE: MDT) ha programado la publicación de sus resultados financieros del cuarto trimestre y del año fiscal completo 2025 para el miércoles 21 de mayo de 2025. La empresa emitirá un comunicado de prensa a las 5:45 a.m. CDT, seguido de una transmisión en video a las 7:00 a.m. CDT para analizar los resultados. El año fiscal 2025 finalizó el 25 de abril de 2025.
El líder en tecnología sanitaria también ha anunciado el calendario de publicación de resultados para el año fiscal 2026, con resultados trimestrales previstos para el 19 de agosto de 2025, 18 de noviembre de 2025, 17 de febrero de 2026 y 20 de mayo de 2026. Medtronic, con sede en Galway, Irlanda, emplea a más de 95,000 personas en más de 150 países, desarrollando tecnologías que tratan 70 condiciones de salud, incluyendo dispositivos cardíacos, robótica quirúrgica y bombas de insulina.
메드트로닉 (NYSE: MDT)은 2025년 5월 21일 수요일에 2025 회계연도 4분기 및 전체 연도 재무 결과를 발표할 예정입니다. 회사는 CDT 기준 오전 5시 45분에 보도자료를 발표하고, 이어서 오전 7시에 결과를 논의하는 비디오 웹캐스트를 진행합니다. 2025 회계연도는 2025년 4월 25일에 종료되었습니다.
이 의료 기술 선도 기업은 2026 회계연도 분기별 실적 발표 일정도 발표했으며, 2025년 8월 19일, 11월 18일, 2026년 2월 17일, 5월 20일에 분기별 결과를 발표할 예정입니다. 아일랜드 골웨이에 본사를 둔 메드트로닉은 150개국 이상에서 95,000명 이상의 직원을 고용하고 있으며, 심장 장치, 수술용 로봇, 인슐린 펌프 등 70가지 건강 상태를 치료하는 기술을 개발하고 있습니다.
Medtronic (NYSE : MDT) a programmé la publication de ses résultats financiers du quatrième trimestre et de l'exercice fiscal complet 2025 pour le mercredi 21 mai 2025. La société publiera un communiqué de presse à 5h45 CDT, suivi d'une webdiffusion vidéo à 7h00 CDT pour discuter des résultats. L'exercice fiscal 2025 s'est terminé le 25 avril 2025.
Le leader en technologies médicales a également annoncé son calendrier de publication des résultats pour l'exercice fiscal 2026, avec des résultats trimestriels prévus les 19 août 2025, 18 novembre 2025, 17 février 2026 et 20 mai 2026. Medtronic, dont le siège est à Galway, en Irlande, emploie plus de 95 000 personnes dans plus de 150 pays, développant des technologies traitant 70 affections, notamment des dispositifs cardiaques, la robotique chirurgicale et les pompes à insuline.
Medtronic (NYSE: MDT) hat die Veröffentlichung der Finanzergebnisse für das vierte Quartal und das gesamte Geschäftsjahr 2025 für Mittwoch, den 21. Mai 2025, geplant. Das Unternehmen wird um 5:45 Uhr CDT eine Pressemitteilung herausgeben, gefolgt von einem Video-Webcast um 7:00 Uhr CDT, um die Ergebnisse zu besprechen. Das Geschäftsjahr 2025 endete am 25. April 2025.
Der führende Anbieter von Medizintechnologie hat außerdem den Zeitplan für die Veröffentlichung der Quartalsergebnisse im Geschäftsjahr 2026 bekannt gegeben, mit Ergebnissen geplant für den 19. August 2025, 18. November 2025, 17. Februar 2026 und 20. Mai 2026. Medtronic mit Hauptsitz in Galway, Irland, beschäftigt über 95.000 Mitarbeiter in mehr als 150 Ländern und entwickelt Technologien zur Behandlung von 70 Gesundheitszuständen, darunter Herzgeräte, chirurgische Robotik und Insulinpumpen.
- None.
- None.
Medtronic will host a video webcast at 7:00 a.m. CDT on May 21, 2025, to discuss results for its fourth quarter and full fiscal year 2025. The webcast can be accessed at https://investorrelations.medtronic.com.
Within 24 hours of the broadcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investorrelations.medtronic.com.
Looking ahead to fiscal year 2026, Medtronic plans to report its first, second, third, and fourth quarter results on Tuesday, August 19, 2025, November 18, 2025, February 17, 2026, and Wednesday, May 20, 2026, respectively. For these events, confirmation and additional details will be provided closer to the specific event.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts:
Erika Winkels
Public Relations
+1-763-526-8478
Ryan Weispfenning
Investor Relations
+1-763-505-4626
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-to-announce-financial-results-for-its-fourth-quarter-and-full-fiscal-year-2025-302449298.html
SOURCE Medtronic plc